BDFS Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$236K Buy
901
+2
+0.2% +$513 0.12% 106
2026
Q2
$226K Buy
+899
New +$193K 0.1% 111
2026
Q1
– Sell
-889
Closed -$203K – 138
2025
Q4
$203K Hold
889
– – 0.1% 133

Other funds holding ABBV

BDFS Capital's ABBV Position: Q3 2026 in Review

BDFS Capital increased its AbbVie (ABBV) stake by 0.22% in Q3 2026, buying an estimated $513 and bringing the position to 901 shares worth $236K. The position accounts for 0.12% of the portfolio, ranked #106.

BDFS Capital first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • BDFS Capital held 901 shares of AbbVie worth $236K as of Q3 2026.
  • BDFS Capital bought 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 0.12% of BDFS Capital's portfolio in Q3 2026, its #106 holding.
  • BDFS Capital first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on BDFS Capital's 13F filing for Q3 2026, filed 14 Oct 2026.